Cite
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study
MLA
Bucello, S., et al. Real World Experience with Teriflunomide in Multiple Sclerosis: The TER-Italy Study. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1242040113&authtype=sso&custid=ns315887.
APA
Bucello, S., Annovazzi, P., Ragonese, P., Altieri, M., Barcella, V., Bergamaschi, R., Bianchi, A., Borriello, G., Buscarinu, M. C., Callari, G., Capobianco, M., Capone, F., Cavalla, P., Cavarretta, R., Cortese, A., De Luca, G., Di Filippo, M., Dattola, V., Fantozzi, R., … Mirabella M. (ORCID:0000-0002-7783-114X). (2021). Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study.
Chicago
Bucello, S., P. Annovazzi, P. Ragonese, M. Altieri, V. Barcella, R. Bergamaschi, A. Bianchi, et al. 2021. “Real World Experience with Teriflunomide in Multiple Sclerosis: The TER-Italy Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1242040113&authtype=sso&custid=ns315887.